Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today released a report revealing how Big Pharma is accelerating investment in AI to counter rising cost pressure, regulatory shifts, and growing competitive urgency. Based on in-depth surveys and interviews with over 40 executives — including leaders from 16 of the top 20 pharma companies and major players like Amazon Web Services, NVIDIA, Oracle Life Sciences, Tempus AI, and Datavant — the r